SNMMI created CTN to facilitate the use of molecular imaging radiopharmaceuticals in multicenter clinical trials. Since its launch, CTN has worked to provide tools and resources to promote faster, more cost-effective drug development and increase the availability and performance of imaging radiopharmaceuticals for clinical use.
###
Ad Statistics
Times Displayed: 112857
Times Visited: 6730 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging, a vital element of today's medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.
SNMMI's more than 18,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.
Media Contact:
Susan Martonik
(703) 652-6773
smartonik@snmmi.org
Back to HCB News
